Jason Rockhill, M.D., Ph.D.
Locations of Practice
1959 NE Pacific Street
Seattle, WA 98195
1570 N 115th Street
Seattle, WA 98133
325 9th Avenue
Seattle, WA 98104
Dr. Rockhill is a radiation oncologist who specializes in treating patients with cancers of the brain and nervous system. He is the program and disease site lead for central nervous system and brain tumors at the University of Washington Department of Radiation Oncology, co-director at the Harborview – Gamma-Knife Center, and co-director at UWMC Neuro Oncology Clinic. Dr. Rockhill practices at UWMC and Harborview.
Patient Care Philosophy
“Being diagnosed with a brain tumor strikes at the very core of an individual. My role is to be part of a multidisciplinary team that provides the best possible support, education & treatment of the individual so they do not have to journey alone.”
Education and Training
College: Claremont McKenna College, Claremont, CA, 1989
Medical Education: University of Illinois College of Medicine Urbana/Champaign, Champaign, IL, 1998
Pre/Post-Doctoral: University of Illinois Urbana/Champaign, Champaign, IL, 2000
Internship: University of Illinois College of Medicine Urbana/Champaign, Internal Medicine, Champaign, IL, 2000
Residency: University of Washington Cancer Center, Radiation Oncology, Seattle, WA, 2004
Selected Publications from a Total of 37
Smith WP, Young LA, Phillips MH, Cheung M, Halasz LM, Rockhill JK. Clinical Positioning Accuracy for Multisession Stereotactic Radiotherapy with the Gamma Knife Perfexion. Technol Cancer Res Treat. 2017 Jan.
Kim M, Kotas J, Rockhill JK, Phillips M. A Feasibility Study of Personalized Prescription Schemes for Glioblastoma Patients Using a Proliferation and Invasion Glioma Model. Cancers (Basel). 2017 May 13;9(5).
Abecassis IJ, Nerva JD, Barber J, Rockhill JK, Ellenbogen RG, Kim LJ, Sekhar LN. Toward a comprehensive assessment of functional outcomes in pediatric patients with brain arteriovenous malformations: the Pediatric Quality of Life Inventory.J Neurosurg Pediatr. 2016 Nov;18(5):611-622.
Nerva JD, Kim LJ, Barber J, Rockhill JK, Hallam DK, Ghodke BV, Sekhar LN. Outcomes of Multimodality Therapy in Pediatric Patients With Ruptured and Unruptured Brain Arteriovenous Malformations. Neurosurgery. 2016 May;78(5):695-707.
Ly KI, Hamilton SR, Rostomily RC, Rockhill JK, Mrugala MM. Improvement in Visual Fields After Treatment of Intracranial Meningioma With Bevacizumab. J Neuroophthalmol. 2015 Dec;35(4):382-6.
Brachman DG, Pugh SL, Ashby LS, Thomas TA, Dunbar EM, Narayan S, Robins HI, Bovi JA, Rockhill JK, Won M, Curran WP. Phase 1/2 Trials of Temozolomide, Motexafin Gadolinium, and 60-Gy Fractionated Radiation for Newly Diagnosed Supratentorial Glioblastoma Multiforme: Final Results of RTOG 0513. Int J Radiat Oncol Bio Phys. 2015 Apr 1; 91(5):961-7.
Cho E, Rubinstein L, Stevenson P, Gooley T, Philips M, Halasz LM, Gensheimer MF, Linden HM, Rockhill JK, Gadi VK. The use of stereotactic radiosurgery for brain metastases from breast cancer: Who benefits most? Breast Cancer Res Treatment. 2015 Feb; 149(3):743-9.
Nerva JD, Mantovani A, Barber J, Kim LJ, Rockhill JK, Hallam DK, Ghodke BV, Sekhar LN. Treatment Outcomes of Unruptured Arteriovenous Malformations With a Subgroup Analysis of ARUBA (A Randomized Trial of Unruptured Brain Arteriovenous Malformations)-Eligible Patients. Neurosurgery 76.5 (2015): 563-570.
Rockne RC, Trister AD, Jacobs J, Hawkins-Daarud AJ, Neal ML, Hendrickson K, Mrugala MM, Rockhill JK, Kinahan P, Krohn KA, Swanson KR. A patient-specific computational model of hypoxia-modulated radiation resistance in glioblastoma using 18F-FMISO-PET. J R Soc Interface. 2015 Feb 6;12(103).
Baldock AL, Yagle K, Born DE, Ahn S, Trister AD, Neal M, Johnston SK, Bridge CA, Basanta D, Scott J, Malone H, Sonabend AM, Canoll P, Mrugala MM, Rockhill JK, Rockne RC, Swanson KR. Invasion and proliferation kinetics in enhancing gliomas predict IDH1 mutation status. Neuro Oncol. 2014 Jun; 6: 779-786.